Mollnes T E, Lea T, Harboe M, Tschopp J
Scand J Immunol. 1985 Aug;22(2):183-95. doi: 10.1111/j.1365-3083.1985.tb01870.x.
The terminal complement complex (TCC), consisting of C5b, C6, C7, C8, and C9, contains neoantigens that are absent from the individual native components. Neoantigens are present both in the membrane-bound (MAC) and the fluid-phase (SC5b-9) complex. The present study describes production of monoclonal antibodies against neoantigens of both forms of the TCC. A convenient screening and detection system, based mainly on enzyme-linked immunosorbent assays, crossed immunoelectrophoresis with autoradiography, and affinity chromatography with subsequent sodium dodecyl sulphate-polyacrylamide gel electrophoresis including immunoblotting, is described in detail. Two monoclonal antibodies were specific for a neoantigen located in the poly(C9) moiety of the TCC. One of these antibodies, MCaE11, was used for immunohistochemical detection of MAC in tissue and for quantification of the fluid-phase TCC in ethylenediaminetetraacetic acid plasma.
终末补体复合物(TCC)由C5b、C6、C7、C8和C9组成,含有单个天然成分中不存在的新抗原。新抗原存在于膜结合(MAC)和液相(SC5b-9)复合物中。本研究描述了针对两种形式TCC新抗原的单克隆抗体的产生。详细描述了一种方便的筛选和检测系统,主要基于酶联免疫吸附测定、放射自显影交叉免疫电泳以及随后包括免疫印迹在内的十二烷基硫酸钠-聚丙烯酰胺凝胶电泳亲和层析。两种单克隆抗体对位于TCC聚(C9)部分的新抗原具有特异性。其中一种抗体MCaE11用于组织中MAC的免疫组织化学检测以及乙二胺四乙酸血浆中液相TCC的定量。